HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Mozavaptan

HCID 119369
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
137975-06-5
Standard SMILES
Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1
InChIKey
WRNXUQJJCIZICJ-UHFFFAOYSA-N
Molecular formula
C27H29N3O2
Average molar mass
427.5 g/mol
Monoisotopic mass
427.22597718

Overview

Mozavaptan is a member of benzamides. It has a role as an aquaretic.

Names & identifiers

Preferred name
Mozavaptan
IUPAC
N-[4-[5-(dimethylamino)-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]phenyl]-2-methylbenzamide
English name
Mozavaptan
Molecular formula
C27H29N3O2
Molecular weight
427.54

Names & synonyms

Mozavaptan137975-06-5Opc-31260MozavaptaneOpc 31260mozavaptanumDTXSID805764117OJ42922YDTXCID90314305-Dimethylamino-1-(4-(2-methylbenzoylamino)benzoyl)-2,3,4,5-tetrahydro-1H-benzazepineN-(4-(((5RS)-5-(Dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl)phenyl)-2-methylbenzamideN-(4-(5-dimethylamino2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)phenyl)-2-methylbenzamide
Show more names
CS-134OPC31260lMozavaptan USP/EP/BPMozavaptan (OPC-31260)N-(4-(5-(Dimethylamino)Mozavaptan, 10 mM in DMSOOPC31260L-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)
N-[4-(5-dimethylamino2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)phenyl]-2-methylbenzamideRefChem:159855Mozavaptan [INN]N-(4-(5-(dimethylamino)-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)phenyl)-2-methylbenzamideMozavaptan free baseMFCD00908918OPC31260N-[4-[5-(dimethylamino)-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]phenyl]-2-methylbenzamide

Properties

Computed structural propertiesFilling in

XLogP
4.5
Topological polar surface area
52.7 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
4
Heavy atoms
32
Formal charge
0
Complexity
643

Physicochemical properties

Melting point
213 · 213 - 217°C
Boiling point
543 · 543.0±50.0 °C(Predicted)
Density
1.21 · 1.21±0.1 g/cm3(Predicted)
storage temp.
Sealed in dry,Room Temperature
solubility
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
form
Solid
pka
13.04 · 13.04±0.70(Predicted)
color
White to Off-White
InChIKey
WRNXUQJJCIZICJ-UHFFFAOYSA-N
SMILES
C(NC1=CC=C(C(N2C3=CC=CC=C3C(N(C)C)CCC2)=O)C=C1)(=O)C1=CC=CC=C1C
FDA UNII
17 OJ42922Y · 17OJ42922Y

Chemistry & industry

Pharmacology

MeSH Pharmacological ClassificationEndogenous compounds and drugs that inhibit or block the activity of ANTIDUIRETIC HORMONE RECEPTORS.
Applications · 3 items

DescriptionMozavaptan is an oral vasopressin V2 antagonist that has been launched in Japan for inappropriate antidiuretic hormone secretion syndrome (IADHS), an affliction manifesting as hyponatremia. It joins another nonpeptidic benzazepine, conivaptan, which corrects sodium and water imbalance by blocking the renal V2 receptor resulting in enhanced diuresis, thereby effectively increasing serum sodium concentration. While conivaptan inhibits both V1 and V2 receptors, mozavaptan is significantly more selective for V2 (IC50 of 14nM vs. 1.2 mM for V1).

UsesMozavaptan is a vasopressin-receptor antagonist. It is used in the treatment of congestive heart failure and hyponatremia.

Usesvasopressin V2 receptor antagonist

Additional notes

DefinitionChEBI: Mozavaptan is a member of benzamides.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
137975-06-5
PubChem CID
119369
DTXSID
DTXSID8057641
ChEMBL
CHEMBL420762
ChEBI
CHEBI:135694
UNII
17OJ42922Y
Nikkaji
J464.170A